Phase II Study of Growth Hormone in Children With Cystic Fibrosis

Completed · Phase 2

Conditions studied: Cystic Fibrosis

In brief

OBJECTIVES: I. Determine the effect of growth hormone on height, height velocity, body weight, and lean body mass in patients with cystic fibrosis. II. Determine the effect of growth hormone on pulmonary function in these patients. III. Determine the impact of this drug on the quality of life in these patients. IV. Determine if the clinical response from this drug is sustained in these patients.

Key facts

Study ID

NCT00016445

Run by

University of Utah

People needed

40

Starts

2001-02-01

Last updated by the study team

2008-09-09

Who can join

Age: 5 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Phoenix Children's Hospital — Phoenix, Arizona, United States
• Children's Hospital of Orange County — Orange, California, United States
• James Whitcomb Riley Hospital for Children — Indianapolis, Indiana, United States
• Washington University — St Louis, Missouri, United States
• Children's Medical Center - Dayton — Dayton, Ohio, United States
• T.L. Carey, M.D. and Associates — Tulsa, Oklahoma, United States
• Southwest Medical Center at Dallas — Dallas, Texas, United States
• Cook Children's Medical Center - Fort Worth — Fort Worth, Texas, United States
• Primary Children's Medical Center — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.